Literature DB >> 35938404

Why We Should Care About Who Cares for Patients With Heart Failure With Preserved Ejection Fraction.

Sanjiv J Shah1.   

Abstract

Entities:  

Keywords:  Editorials; cardiology; healthcare providers; heart failure; hospitalization; process assessment (health care)

Mesh：

Year:  2022        PMID： 35938404      PMCID： PMC9388547          DOI： 10.1161/CIRCHEARTFAILURE.122.009867

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   10.447


× No keyword cloud information.
  14 in total

1.  Phenomapping for novel classification of heart failure with preserved ejection fraction.

Authors:  Sanjiv J Shah; Daniel H Katz; Senthil Selvaraj; Michael A Burke; Clyde W Yancy; Mihai Gheorghiade; Robert O Bonow; Chiang-Ching Huang; Rahul C Deo
Journal:  Circulation       Date:  2014-11-14       Impact factor: 29.690

Review 2.  How to Develop and Implement a Specialized Heart Failure with Preserved Ejection Fraction Clinical Program.

Authors:  Sanjiv J Shah; Rebecca Cogswell; John J Ryan; Kavita Sharma
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

3.  Outcomes of patients with acute decompensated heart failure managed by cardiologists versus noncardiologists.

Authors:  Shanmugam Uthamalingam; Jagdesh Kandala; Vijairam Selvaraj; William Martin; Marlyn Daley; Eshan Patvardhan; Robert Capodilupo; Stephanie Moore; James L Januzzi
Journal:  Am J Cardiol       Date:  2014-12-02       Impact factor: 2.778

4.  Spironolactone for heart failure with preserved ejection fraction.

Authors:  Bertram Pitt; Marc A Pfeffer; Susan F Assmann; Robin Boineau; Inder S Anand; Brian Claggett; Nadine Clausell; Akshay S Desai; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; Brian Harty; John F Heitner; Christopher T Kenwood; Eldrin F Lewis; Eileen O'Meara; Jeffrey L Probstfield; Tamaz Shaburishvili; Sanjiv J Shah; Scott D Solomon; Nancy K Sweitzer; Song Yang; Sonja M McKinlay
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

5.  Empagliflozin in Heart Failure with a Preserved Ejection Fraction.

Authors:  Stefan D Anker; Javed Butler; Gerasimos Filippatos; João P Ferreira; Edimar Bocchi; Michael Böhm; Hans-Peter Brunner-La Rocca; Dong-Ju Choi; Vijay Chopra; Eduardo Chuquiure-Valenzuela; Nadia Giannetti; Juan Esteban Gomez-Mesa; Stefan Janssens; James L Januzzi; Jose R Gonzalez-Juanatey; Bela Merkely; Stephen J Nicholls; Sergio V Perrone; Ileana L Piña; Piotr Ponikowski; Michele Senni; David Sim; Jindrich Spinar; Iain Squire; Stefano Taddei; Hiroyuki Tsutsui; Subodh Verma; Dragos Vinereanu; Jian Zhang; Peter Carson; Carolyn Su Ping Lam; Nikolaus Marx; Cordula Zeller; Naveed Sattar; Waheed Jamal; Sven Schnaidt; Janet M Schnee; Martina Brueckmann; Stuart J Pocock; Faiez Zannad; Milton Packer
Journal:  N Engl J Med       Date:  2021-08-27       Impact factor: 176.079

6.  Temporal Trends of Heart Failure Hospitalizations in Cardiology Versus Noncardiology Wards According to Ejection Fraction: 16-Year Data From the SwedeHF Registry.

Authors:  Marco Canepa; Chris J Kapelios; Lina Benson; Gianluigi Savarese; Lars H Lund
Journal:  Circ Heart Fail       Date:  2022-08-08       Impact factor: 10.447

Review 7.  Research Priorities for Heart Failure With Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary.

Authors:  Sanjiv J Shah; Barry A Borlaug; Dalane W Kitzman; Andrew D McCulloch; Burns C Blaxall; Rajiv Agarwal; Julio A Chirinos; Sheila Collins; Rahul C Deo; Mark T Gladwin; Henk Granzier; Scott L Hummel; David A Kass; Margaret M Redfield; Flora Sam; Thomas J Wang; Patrice Desvigne-Nickens; Bishow B Adhikari
Journal:  Circulation       Date:  2020-03-23       Impact factor: 29.690

8.  Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.

Authors:  Salim S Virani; Alvaro Alonso; Hugo J Aparicio; Emelia J Benjamin; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Susan Cheng; Francesca N Delling; Mitchell S V Elkind; Kelly R Evenson; Jane F Ferguson; Deepak K Gupta; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Chong D Lee; Tené T Lewis; Junxiu Liu; Matthew Shane Loop; Pamela L Lutsey; Jun Ma; Jason Mackey; Seth S Martin; David B Matchar; Michael E Mussolino; Sankar D Navaneethan; Amanda Marma Perak; Gregory A Roth; Zainab Samad; Gary M Satou; Emily B Schroeder; Svati H Shah; Christina M Shay; Andrew Stokes; Lisa B VanWagner; Nae-Yuh Wang; Connie W Tsao
Journal:  Circulation       Date:  2021-01-27       Impact factor: 29.690

9.  The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.

Authors:  Michael E Nassif; Sheryl L Windsor; Barry A Borlaug; Dalane W Kitzman; Sanjiv J Shah; Fengming Tang; Yevgeniy Khariton; Ali O Malik; Taiyeb Khumri; Guillermo Umpierrez; Sumant Lamba; Kavita Sharma; Sadiya S Khan; Lokesh Chandra; Robert A Gordon; John J Ryan; Sunit-Preet Chaudhry; Susan M Joseph; Chen H Chow; Manreet K Kanwar; Michael Pursley; Elias S Siraj; Gregory D Lewis; Barry S Clemson; Michael Fong; Mikhail N Kosiborod
Journal:  Nat Med       Date:  2021-10-28       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.